✦ LIBER ✦

Mucositis after Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study of Methotrexate- and Non-Methotrexate-Containing Graft-versus-Host Disease Prophylaxis Regimens

✍ Scribed by Corey Cutler; Shuli Li; Haesook T. Kim; Patricia Laglenne; Kwok Chuen Szeto; Laura Hoffmeister; M. Joel Harrison; Vincent Ho; Edwin Alyea; Stephanie J. Lee; Robert Soiffer; Stephen Sonis; Joseph H. Antin

Book ID: 116278307
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 205 KB
Volume: 11
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2005.02.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of methotrexate- versus sirol

Comparison of methotrexate- versus sirolimus-containing graft-versus-host disease prophylaxis regimens after myeloablative stem cell transplantation

✍ A.M. Saito; C. Cutler; D. Zahrieh; R.J. Soiffer; V.T. Ho; E.P. Alyea; J.H. Antin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Low-dose methotrexate for the treatment

Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

✍ Huang, X-J; Jiang, Q; Chen, H; Xu, L; Liu, D; Chen, Y; Han, W; Zhang, Y; Liu, K; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 114 KB

Feasibility of tacrolimus, methotrexate,

Feasibility of tacrolimus, methotrexate, and prednisolone as a graft-versus-host disease prophylaxis in non-T-cell-depleted haploidentical hematopoietic stem cell transplantation for children

✍ Kazuhiro Mochizuki; Atsushi Kikuta; Masaki Ito; Hideki Sano; Mitsuko Akaihata; S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Omission of day +11 methotrexate does no

Omission of day +11 methotrexate does not appear to influence incidence and severity of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

✍ Kang-er Zhu; Tao Zhang; Sheng-ting Cheng; Juan Zhong; Hui-lan Zeng 📂 Article 📅 2004 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 386 KB

Bortezomib, tacrolimus, and methotrexate

Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors

✍ Koreth, J.; Stevenson, K. E.; Kim, H. T.; Garcia, M.; Ho, V. T.; Armand, P.; Cut 📂 Article 📅 2009 🏛 American Society of Hematology 🌐 English ⚖ 206 KB

The impact of methylenetetrahydrofolate

The impact of methylenetetrahydrofolate reductase C677T gene polymorphism on engraftment after allogeneic hematopoietic cell transplantation in patients receiving methotrexate in graft versus host disease prophylaxis

✍ M. Arat; E. Soydan; P. Topcuoglu; M. Ozcan; O. Arslan; G. Gurman; O. Ilhan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB